Matches in Wikidata for { <http://www.wikidata.org/entity/Q58051904> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q58051904 description "article scientifique publié en 2006" @default.
- Q58051904 description "article" @default.
- Q58051904 description "im April 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58051904 description "wetenschappelijk artikel" @default.
- Q58051904 description "наукова стаття, опублікована у квітні 2006" @default.
- Q58051904 name "Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group" @default.
- Q58051904 name "Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group" @default.
- Q58051904 type Item @default.
- Q58051904 label "Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group" @default.
- Q58051904 label "Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group" @default.
- Q58051904 prefLabel "Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group" @default.
- Q58051904 prefLabel "Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group" @default.
- Q58051904 P1433 Q58051904-12A81D76-0E66-4F25-AC9F-A3E26342ABB7 @default.
- Q58051904 P1476 Q58051904-6C81FF92-61E7-4390-945B-17809ED92795 @default.
- Q58051904 P2093 Q58051904-3613C0BE-9423-4666-8D50-AAA1E1703DBF @default.
- Q58051904 P2093 Q58051904-4A7CD113-E9F0-4A85-8817-D41B82F068D9 @default.
- Q58051904 P2093 Q58051904-5D710860-ECE8-4936-B55E-9A2EB5290615 @default.
- Q58051904 P2093 Q58051904-6CA0DE80-C48A-421E-8992-2384340E4EE5 @default.
- Q58051904 P2093 Q58051904-80821BAE-68EF-4DD9-819F-45758D0162D6 @default.
- Q58051904 P2093 Q58051904-86F029AF-B51A-44B8-A9B6-AC404357C301 @default.
- Q58051904 P2093 Q58051904-8ECB9B8C-D23A-443F-94E5-E1F3F22D7B3D @default.
- Q58051904 P2093 Q58051904-9D98BA9A-4F83-46E3-8B46-0B0B81A5C5E1 @default.
- Q58051904 P2093 Q58051904-CE09F933-B4BE-4F7E-9DA5-8A6E1F5F2D78 @default.
- Q58051904 P304 Q58051904-DC70BB0D-677E-41E2-86EA-1DC9E3C72DE2 @default.
- Q58051904 P31 Q58051904-C701A420-47E5-492A-B5C1-667AD01F914B @default.
- Q58051904 P356 Q58051904-3CD8A25F-748C-4D85-B9B6-AAF270D0D424 @default.
- Q58051904 P407 Q58051904-96730AE9-8C1B-4AED-B299-B431F097D1DB @default.
- Q58051904 P433 Q58051904-A1690D00-5832-4BC9-84FA-865F9D64BBDD @default.
- Q58051904 P478 Q58051904-584F4420-F326-4060-9DD3-5DF89DB5A6F1 @default.
- Q58051904 P50 Q58051904-11BBBDCA-8A5B-494F-B560-994007C62923 @default.
- Q58051904 P50 Q58051904-12837AE3-364C-471D-9C32-3C791604F987 @default.
- Q58051904 P50 Q58051904-740AB608-A81F-4857-843A-4EAC08200983 @default.
- Q58051904 P577 Q58051904-E0200C81-CE35-45AD-AABE-BE3F2A4ED3C2 @default.
- Q58051904 P698 Q58051904-7CAE68DE-0C73-4B0D-8B2A-C871210CB99C @default.
- Q58051904 P921 Q58051904-37478231-5DE2-43AA-B762-BF12B0008025 @default.
- Q58051904 P921 Q58051904-DEC18E60-7655-4777-8272-E490BD79C8F5 @default.
- Q58051904 P921 Q58051904-E0820858-424E-49DB-B6CD-C4DCBDB00694 @default.
- Q58051904 P356 JCO.2005.04.4917 @default.
- Q58051904 P698 16549819 @default.
- Q58051904 P1433 Q400292 @default.
- Q58051904 P1476 "Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group" @default.
- Q58051904 P2093 "Bernard Charbonnel" @default.
- Q58051904 P2093 "Chien-Hsing Chang" @default.
- Q58051904 P2093 "David M Goldenberg" @default.
- Q58051904 P2093 "French Endocrine Tumor Group" @default.
- Q58051904 P2093 "Jean-François Chatal" @default.
- Q58051904 P2093 "Jean-Philippe Vuillez" @default.
- Q58051904 P2093 "Robert M Sharkey" @default.
- Q58051904 P2093 "Stephane Bardet" @default.
- Q58051904 P2093 "Vincent Rohmer" @default.
- Q58051904 P304 "1705-1711" @default.
- Q58051904 P31 Q13442814 @default.
- Q58051904 P356 "10.1200/JCO.2005.04.4917" @default.
- Q58051904 P407 Q1860 @default.
- Q58051904 P433 "11" @default.
- Q58051904 P478 "24" @default.
- Q58051904 P50 Q40319499 @default.
- Q58051904 P50 Q42165930 @default.
- Q58051904 P50 Q43992848 @default.
- Q58051904 P577 "2006-03-20T00:00:00Z" @default.
- Q58051904 P698 "16549819" @default.
- Q58051904 P921 Q1145523 @default.
- Q58051904 P921 Q181600 @default.
- Q58051904 P921 Q18556131 @default.